Viveve Announces Preliminary Topline Financial Results for Fourth Quarter 2020
Q4 revenue growth, reduced operating expenses, and successful closing of public offering in January position Company with capital resources through...
News
Hepion Pharmaceuticals, Inc. Announces Closing of Public Offering
EDISON, NJ / ACCESSWIRE / February 18, 2021 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), today announced the closing of its previously...
Capstone Therapeutics Announces Results of Special Shareholder Meeting, and a License Transfer/Royalty Agreement and Exit from the Pharmaceutical Development Business
ALSIP, IL / ACCESSWIRE / February 18, 2021 / Capstone Therapeutics (OTCQB:CAPS) ("the Company") On February 5, 2021, the Company...
PartsSource® Releases PartsSource Pro® 2021: Adding Advisory Services, Formulary Starter Sets and Expanded Guaranteed Stock to Improve Uptime and Accelerate Productivity
CLEVELAND--(BUSINESS WIRE)--PartsSource, the only evidence-based marketplace that combines data-driven decision support with automation to simplify medical device products and services...
PPD Awarded US Army Study to Help Develop Post-Traumatic Stress Disorder Drugs
Adaptive platform clinical research trial design to expedite potential new treatments for veterans WILMINGTON, N.C.--(BUSINESS WIRE)--PPD, Inc. (Nasdaq: PPD), a...
Wellsheet Featured in KLAS Spotlight Targeting Physician Burnout
100% of Respondents Would Buy Wellsheet Again for Quick Access to Relevant Electronic Health Record Data to Reduce Time in...
Seduction Cosmetic Center Now Offering Revolutionary J-Plasma Procedure
Miami's famous Seduction Cosmetic Center introduces Renuvion's J-Plasma procedure to its roster of cutting-edge treatment solutionsMIAMI, FL / ACCESSWIRE /...
Inspyr Therapeutics Further Strengthens Global Intellectual Property
WESTLAKE VILLAGE, CA / ACCESSWIRE / February 18, 2021 / Inspyr Therapeutics, Inc. (OTC PINK:NSPX), a pharmaceutical company focused on...
Key Capital Strengthens Vaccine Patents
Full Patent for Immunitor issued in China and EU Claims being re-filed NEW YORK, NY / ACCESSWIRE / February 18,...
Limitless Changes to December 31 Fiscal Year End Expects to Report Record Revenues
TULSA, OK / ACCESSWIRE / February 18, 2021 / Limitless Venture Group, Inc. (OTC PINK:LVGI), a publicly-traded holding company that...
Jaguar Health Signs Memorandum of Understanding with the Lead Sponsor of the Planned Dragon SPAC Pursuing Listing on AIM Italia, Providing the Dragon SPAC with Exclusivity for a Proposed Business Combination with Napo EU
Napo EU to explore conditional marketing authorization for proposed inflammatory diarrhea indication for crofelemer, initially in ‘long-hauler' covid-19 recovery patients...
CureVac to Participate in Upcoming Investor Conferences
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / February 18, 2021 / CureVac N.V. (NASDAQ:CVAC), a global biopharmaceutical company developing...
CLS Holdings USA, Inc. Welcomes New Board Member, Mr. Ross Silver
LAS VEGAS, NV / ACCESSWIRE / February 18, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), the ''Company'' or ''CLS'', a...
MannKind Corporation to Hold 2020 Fourth Quarter and Full Year Financial Results Conference Call on February 25, 2021
WESTLAKE VILLAGE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) will release its 2020 fourth quarter and full...
Turning Point Therapeutics to Host Fourth Quarter and Full-Year 2020 Conference Call
SAN DIEGO, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation...
Predictive Oncology Announces $17.6 Million Private Placement Priced At-the-Market
MINNEAPOLIS, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company...
Courtney Barton Joins Arcutis as Chief Compliance Officer and Chief of Staff
WESTLAKE VILLAGE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on...
GBS Inc. Enters Sponsored Research Agreement with Johns Hopkins Bloomberg School of Public Health To Accelerate Development of Saliva-Based Diagnostic Tests
NEW YORK, Feb. 18, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company that develops non-invasive, real-time...
Ocuphire Initiates Enrollment in VEGA-1 Phase 2 Trial Investigating Nyxol in Presbyopia
Nyxol and Low-Dose (0.4%) Pilocarpine Combination to Target Improvement in Near Vision in a Presbyopic Population Top Line Data from...
Alimera Sciences Continues Global Geographic Expansion With Launch of ILUVIEN in Finland for Both Indications
ATLANTA, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the...